ASTEROID 4: Uterine Fibroid Study
Why is this study being done?
Uterine fibroids are extremely common benign uterine tumors that can cause heavy menstrual bleeding and pelvic discomfort. When uterine fibroid symptoms begin to negatively impact a woman's quality of life, many women seek treatment. The most common and definitive treatment for fibroids is surgical removal of the fibroid or hysterectomy. Many women wish to avoid surgery. Therefore, an effective non-surgical treatment for uterine fibroids needs to be developed. Currently, there is no approved medication in the US that addresses the need for a prolonged treatment strategy that serves as an acceptable alternative to surgery. Data from this study could help develop a non-surgical long term treatment method for women with uterine fibroids.
You may be eligible for this study if:
- You are a generally healthy woman at least 18 years of age
- You have a diagnosis of uterine fibroids and/or have had surgical treatment for uterine fibroids within 3 months but have a high risk for recurrence.
- You are suffering from heavy menstrual bleeding due to uterine fibroids
Qualified participants will be compensated up to $1,875 for time and travel during the 16 month study. Study participation involves 8 in person visits to the OHSU Marquam Hill campus clinic. Study participants will also be expected to complete an electronic daily diary.